Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × UNKNOWN × Colonic Neoplasms × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

OTHER 56 INDUSTRY 49 NIH 16 UNKNOWN 1 OTHER_GOV 1 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2 Colorectal Neoplasms 2 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Hodgkin Disease 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Adenocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03545711 2018-08-06

Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer

ChineseAMS

Phase 1/2 Unknown

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡